MAPT and tauopathy: The use of VHH in tauopathies is also considered: a VHH directed against the PHF6 motif of tau, a nucleation core, proved to be efficient against tau fibril formation in in vitro and cellular models, and showed efficacy in preventing tau seeding in a mouse model (Dupré et al., 2019; Danis et al., 2022).